Handa Pharmaceuticals Inc · TPEX:6620

Handa Pharmaceuticals Inc financial statements

Handa Pharmaceuticals Inc's income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in TWD

Income statement

LineFY2025FY2024FY2023FY2022FY2021
Revenue1.73B830.7M1.11B197.7M29.2M
Cost of revenue267.5M1.17M1.30M18.7M1.46M
Gross profit1.46B829.5M1.11B179.0M27.8M
Research and development362.6M291.9M267.3M179.8M209.0M
Selling, general and administrative165.0M119.5M144.3M87.3M72.7M
Operating income934.2M418.1M693.4M-88.1M-253.9M
Depreciation and amortization164.1M10.4M12.4M15.2M35.2M
EBITDA1.10B428.5M705.9M-72.9M-218.7M
Interest expense2.20M492.0K222.0K281.0K232.0K
Income before tax937.0M479.2M792.5M-43.1M-260.8M
Net income749.8M472.7M726.9M-40.0M-247.7M
Earnings per share, basic4.453.375.15-0.30-1.98

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021
Cash and equivalents1.81B597.4M667.0M365.9M263.3M
Short-term investments1.90B1.23B1.65B2.59M33.3M
Receivables580.0M190.4M376.4M153.5M7.79M
Inventory041.2M0
Current assets4.31B2.11B2.71B592.9M314.3M
Goodwill35.9M35.9M34.9M34.9M34.9M
Total assets5.89B3.44B3.04B790.6M498.5M
Accounts payable30.2M20.8M14.0M6.22M1.08M
Current liabilities117.8M241.4M209.5M45.4M29.7M
Total liabilities232.1M324.1M280.9M69.4M35.4M
Shareholders' equity5.66B3.12B2.76B721.1M463.1M
Shares outstanding168.5M140.5M141.1M132.2M125.0M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021
Cash from operations243.6M497.6M668.4M-211.6M-179.2M
Capital spending-17.1M-7.77M-944.0K-758.0K-7.15M
Free cash flow226.5M489.8M667.4M-212.3M-186.4M
Dividends paid-236.3M-141.1M
Share buybacks-57.9M-56.5M0
Change in cash1.21B-69.7M301.1M102.6M-16.8M